XTLB (XTL Biopharmaceuticals) OCF Yield %: -28.15 (As of Jun. 27, 2026)


XTLB XTL Biopharmaceuticals Ltd XTLB
24 GF Score
Price $2.35
! 2 Warning Signs
View Full Analysis

What is XTL Biopharmaceuticals OCF Yield %?

XTL Biopharmaceuticals XTLB -7.99% 24 OCF Yield % is -28.15 as of Jun. 27, 2026. GuruFocus rates XTLB with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 1,419 Biotechnology companies, XTL Biopharmaceuticals ranks worse than 74.49% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, XTL Biopharmaceuticals's Trailing 12-Month Cash Flow from Operations is $0.00 Mil, and Market Cap is $5.71 Mil. Therefore, XTL Biopharmaceuticals's OCF Yield % for today is -28.15%.

The historical rank and industry rank for XTL Biopharmaceuticals's OCF Yield % or its related term are showing as below:

XTLB' s OCF Yield % Range Over the Past 10 Years
Min: -40.06   Med: -16.82   Max: -9.87
Current: -28.15

During the past 13 years, the highest OCF Yield % of XTL Biopharmaceuticals was -9.87%. The lowest was -40.06%. And the median was -16.82%.

XTLB's OCF Yield % is ranked worse than
74.49% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs XTLB: -28.15

XTL Biopharmaceuticals's OCF Margin % for the quarter that ended in Jun. 2025 was %.

XTL Biopharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

XTL Biopharmaceuticals OCF Yield % Related Terms

XTL Biopharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for XTL Biopharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XTL Biopharmaceuticals OCF Yield % Chart

XTL Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.45 -6.95 -13.67 -12.85 -9.06

XTL Biopharmaceuticals Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XTLB vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, XTL Biopharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XTL Biopharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XTL Biopharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where XTL Biopharmaceuticals's OCF Yield % falls into.


XTLB
24GF Score
XTL Biopharmaceuticals Ltd XTLB
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XTL Biopharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

XTL Biopharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-1.618 / 17.8513496
=-9.06%

XTL Biopharmaceuticals's annualized OCF Yield % for the quarter that ended in Jun. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 2 / 10.04568
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -28.15 mean?
XTL Biopharmaceuticals (XTLB) has a OCF Yield % of -28.15 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on XTL Biopharmaceuticals and its competitors. According to the industry distribution chart, XTL Biopharmaceuticals ranks #1057 out of 1419 companies in the Biotechnology industry, placing it in the top 74.5%.
Is XTL Biopharmaceuticals' OCF Yield % too high?
XTL Biopharmaceuticals' current OCF Yield % is -28.15. Based on the distribution chart, XTL Biopharmaceuticals ranks #1057 out of 1419 companies in the Biotechnology industry, which is below the industry midpoint. Overall, XTL Biopharmaceuticals has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does XTL Biopharmaceuticals' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, XTL Biopharmaceuticals ranks #1057 out of 1419 companies for OCF Yield %. This places XTL Biopharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on XTL Biopharmaceuticals and its competitors. XTL Biopharmaceuticals's current OCF Yield % is -28.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XTL Biopharmaceuticals stock overvalued right now?
XTL Biopharmaceuticals (XTLB) has a current OCF Yield % of -28.15. The current OCF Yield % is -28.15. XTL Biopharmaceuticals' overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For XTL Biopharmaceuticals (XTLB), the current OCF Yield % is -28.15 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XTL Biopharmaceuticals Business Description

Other Exchanges XTLB:IsraelHHB0:Germany
Address 26 Ben-Gurion Street, Ramat Gan, ISR, 5112001
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
24GF Score

Get the complete analysis for XTLB

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price